P2X7 receptor signaling promotes inflammation in renal parenchymal cells suffering from ischemia-reperfusion injury

• Published in: Cell death & disease Vol. 12; no. 1; p. 132
• Main Authors: Qian, Yingying, Qian, Cheng, Xie, Kewei, Fan, Qicheng, Yan, Yucheng, Lu, Renhua, Wang, Lin, Zhang, Minfang, Wang, Qin, Mou, Shan, Dai, Huili, Ni, Zhaohui, Pang, Huihua, Gu, Leyi
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 27.01.2021; Springer Nature B.V; Nature Publishing Group
• Subjects: 13/1; 13/51; 13/89; 38/22; 45/77; 45/90; 631/45/612/1237; 631/80/304; 64/60; 692/699/1585/4; 82/80; 96/21; 96/35; 96/63; Adenosine triphosphate; Antibodies; Apyrase; ATP; Biochemistry; Biomedical and Life Sciences; Bone marrow; Cell Biology; Cell Culture; Chimeras; Clear cell-type renal cell carcinoma; Creatinine; Epithelial cells; Epithelium; Hypoxia; IL-1β; Immunology; Inflammasomes; Ischemia; Kidneys; Life Sciences; Nephrectomy; Oligomerization; Reperfusion
• ISSN: 2041-4889; 2041-4889
• DOI: 10.1038/s41419-020-03384-y

Extracellular adenosine triphosphate (ATP) and its receptor, P2X7 receptor (P2X7R), are playing an important role in the pathological process of renal ischemia-reperfusion injury, but their underlying mechanism remains unclear. Also, the effects of tubular epithelium-expressed P2X7 receptor on ischemia acute kidney injury is still unknown. The aim of this study is to clarify if this mechanism involves the activation of nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) inflammasome in the renal tubular epithelial cells. In our research, we used male C57BL/6 wild type and P2X7R (−/−) mice, cultured human proximal tubular epithelial cells, and kidneys from acute kidney injury patients. Mice underwent for unilateral nephrectomy combined with the lateral renal pedicle clamping. Cultured cells were subjected to hypoxia/reoxygenation or ATP. Apyrase and A438079 were used to block the extracellular ATP/P2X7 receptor pathway. We also constructed radiation-induced bone marrow (BM) chimeras by using P2X7R (−/−) mice and P2X7R (+/+) wild-type mice. P2X7 receptor deficiency protected from renal ischemia-reperfusion injury and attenuated the formation of NLRP3 inflammasome. By using BM chimeras, we found a partial reduction of serum creatinine and less histological impairment in group wild-type BM to P2X7R (−/−) recipient, compared with group wild-type BM to wild-type recipient. In renal tubular epithelial cells, hypoxia/reoxygenation induced ATP release and extracellular ATP depletion reduced the expression of active IL-1β. ATP activated the NLRP3 inflammasome in renal tubular epithelial cells, which were blunted by transient silence of P2X7 receptor, as well as by P2X7 receptor blocking with A438079. In human samples, we found that patients with Stage 3 AKI had higher levels of P2X7 receptor expression than patients with Stage 1 or Stage 2. Extracellular ATP/P2X7 receptor axis blocking may protect renal tubular epithelial cells from ischemia-reperfusion injury through the regulation of NLRP3 inflammasome.